Contract
New Business Designer
Real Chemistry
1,001-5,000 employees
Delivers AI-powered, patient-centered healthcare experiences
Compensation Overview
$75 - $85/hr
New Hope, PA, USA + 4 more
More locations: Boston, MA, USA | Chicago, IL, USA | Carmel, IN, USA | New York, NY, USA
Hybrid
Hybrid: if within an hour of an office, 2 days/week in-person; otherwise remote with quarterly in-person gatherings.
 UI/UX & Design (1) |
|---|
- 8-10+ years of experience in presentation design, design production, or similar role, preferably within an agency, consulting, or new business environment
- Advanced proficiency in PowerPoint, with a strong understanding of master slides, templates, and layout systems
- Solid design fundamentals, including typography, layout, hierarchy, and visual storytelling
- Experience with graphic design using tools such as Adobe Creative Suite (e.g., Illustrator, InDesign) or comparable tools
- Ability to work quickly and accurately under tight deadlines while maintaining attention to detail
- A collaborative, solutions‑oriented mindset and comfort working with cross‑functional partners
- Design and build high‑impact pitch decks primarily in PowerPoint, ensuring clarity, consistency, and visual polish
- Create custom PowerPoint templates and slide systems tailored to individual new business opportunities, while aligning with Real Chemistry brand guidelines
- Translate strategic and written content into clean, engaging layouts that tell a cohesive story
- Apply lgraphic design support as needed (e.g., charts, icons, simple illustrations, visual frameworks)
- Partner closely with new business, strategy, and creative teams to meet tight deadlines and evolving pitch needs
- Ensure all materials meet Real Chemistry’s quality, accessibility, and brand standards
- Experience supporting new business, pitches, RFIs/RFPs, or growth initiatives
- Familiarity with healthcare, life sciences, or highly regulated industries
- Experience adapting or extending established brand systems within presentations
Real Chemistry helps healthcare brands grow by creating AI-powered, customer-centered healthcare experiences. It combines AI-enabled experiences with cross-disciplinary teams to design and deliver programs across patient, provider, and payer touchpoints. The company differentiates itself through large, integrated teams of specialists focused exclusively on healthcare and customer experience under one mission. Its goal is to transform how healthcare is experienced while driving commercial success for healthcare organizations.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
San Francisco, California
Founded
2001
Simplify's Take
What believers are saying
- International team grew 25% since 2023, exceeding 300 employees outside U.S.
- Acquisitions of Spring & Bond and Greater Than One add 250 media experts.
- Double-digit revenue growth in 2024 from AI-driven healthcare marketing.
What critics are saying
- Spring & Bond integration fails, causing service disruptions in 6-12 months.
- New leaders Kath Harrison and Brandon Pletsch depart within 12-18 months.
- RC Resolve loses clients amid drug pricing scrutiny in 3-9 months.
What makes Real Chemistry unique
- RC Resolve advisory practice deploys ReputAI and HealthGEO for pharma reputation management.
- Spring & Bond acquisition delivers omnichannel precision media for healthcare clients.
- Global hubs in Munich, Zurich, Dubai serve multi-market pharma regulatory needs.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Real Chemistry who can refer or advise you
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Wellness Program
Mental Health Support
Paid Vacation
Company News
Real Chemistry, a global healthcare communications firm, has appointed four senior international leaders and expanded its regional hub presence as part of its global growth strategy. The company is opening new offices in Munich, Zurich and Dubai, with further expansion planned. The appointments include Kath Harrison as Group President, International Growth; Brandon Pletsch as President, Europe; Louise Clark as President, Integrated Communications, Global; and Eleanor Read as President, Integrated Communications, Europe. The leaders bring decades of experience advising global pharmaceutical companies. Since 2023, Real Chemistry's international team has grown 25%, with over 300 employees now working outside the United States. The expansion aims to support healthcare clients navigating complex multi-market environments across Europe, the Middle East, Asia Pacific and Latin America.
Real Chemistry launches new advisory practice to elevate pharma's corporate brand reputation. Real Chemistry unveiled its new advisory practice, focused on corporate communications and reputation, in advance of the JPMorgan Healthcare Conference. Real Chemistry has launched a new advisory practice that will seek to offer guidance to healthcare and pharma companies from a corporate communications and reputation standpoint. The agency unveiled the advisory, dubbed RC Resolve, in advance of the JPMorgan Healthcare Conference next week. It will focus on the intersection of science, policy, risk management and corporate communications - an area that pharma companies have recognized as increasingly important since the COVID-19 pandemic, according to Jennifer Gottlieb, global president and head of integrated communications at Real Chemistry. "Pharma companies realize they can't just rely on doing communications about each individual product, and that consumers are starting to see them as a company that they need to have a relationship with," Gottlieb explained. RC Resolve launched with three goals, Gottlieb noted, including being an advisory team that's solely focused on healthcare and bringing in a team of executives with experience on the pharma client side. It also aims to incorporate Real Chemistry's data and analytics expertise alongside a proprietary suite of tools including ReputAI and HealthGEO. ReputAI is a reputation measurement and predictive message-testing suite that's designed to manage tough reputation situations and crises, according to Gottlieb, that "measures the back end of reputation and works to improve the trust your organization has with its stakeholders." HealthGEO, which Real Chemistry launched last year, is its generative engine optimization (GEO) tool which helps marketers understand how their companies and brands are showing up in AI platforms and large language models (LLMs). The tool allows marketers to understand where misinformation about their brand may be coming from, and gives them pathways to clarify and fix how it's being perceived. RC Resolve will be manned by several executives who come with communications and reputation experience from the pharma client side, including Bridget Walsh, who will serve as head of policy, public affairs and access. Previously, Walsh served in government affairs and policy leadership roles at Pfizer and Boehringer Ingelheim. Amy Atwood, who previously worked as vice president, U.S. and global corporate communications at Takeda, will serve as RC Resolve's head of transformation and change management. Other appointments include Piper Evans, head of corporate strategy and reputation, who previously worked at McKinsey and the Public Affairs Council. Gottlieb pointed to the external pressures occurring in the healthcare industry in recent years - from biotech funding ebbing and flowing, drug pricing debates, and conversations about healthcare access in the U.S. compared to other countries. As a result, the role of the chief communications or chief corporate affairs officer has become increasingly important in the pharma industry, notes Sherry Pudloski, group president at RC Resolve and corporate affairs at Real Chemistry. "We are mirroring the need of the executive who sits at that table - who is responsible for the external environment and internal environment - and being there to serve his or her needs," Pudloski said. "We want to partner with that person to help guide their executive team on how to make wise multi-stakeholder decisions." That includes battling misinformation in an era where science messaging can be beleaguered by external and political forces. "Clarifying the mis- and disinformation, and making sure that patients are continuing to get the shortest road home to the information they need to get to the best care possible, will continue to be our North Star," Gottlieb said.
Real Chemistry continues to strengthen its media capabilities by acquiring Spring & Bond.
Real Chemistry strengthens media and omnichannel leadership with acquisition of Spring & Bond. Second Acquisition in Three Months Builds Momentum NEW YORK-(BUSINESS WIRE)-Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare industry, continues to strengthen its media capabilities by acquiring Spring & Bond. A digital media agency known for its omnichannel-first approach and data-driven solutions, Spring & Bond is focused exclusively on healthcare, working with leading healthcare clients. "Real Chemistry is redefining the future of media with a focus on precision over scale. Our expanded media group offers omni-first precision marketing, which is essential for healthcare marketers aiming for personalized audience messaging," said Kevin Johnson, Group President and Managing Partner of Real Chemistry. "Spring & Bond brings a deep knowledge of the healthcare ecosystem, and advanced data and technology capabilities, enabling our clients to connect more meaningfully and effectively with their target audiences." This acquisition follows Real Chemistry's July acquisition of Greater Than One. Together, Real Chemistry's media group now provides end-to-end media activation solutions with over 250 dedicated experts. This includes: * Starting with the right data and healthcare expertise to understand audiences and inform content strategies * Proprietary planning tools that can drive channel strategy and predict future impact * Connecting first-party data across channels to reach precise audiences * True end to end omnichannel strategy, orchestration and execution * Agile, automated measurement, reporting, and optimization Elizabeth Beringer, President and Founder of Spring & Bond, will continue to lead the team, reporting to Johnson. "Joining Real Chemistry enables us to bring even more tools, insights and expertise to our clients," said Elizabeth Beringer. "Finding a partner like Real Chemistry where the focus on clients, innovation and people match ours is the perfect combination." About Real Chemistry Real Chemistry is a commercialization partner to the world's most successful life sciences and healthcare companies. As a leading provider of AI-powered marketing, communications, medical communications and precision media, Herbert Group help the healthcare industry better understand, reach, and engage communities, patients and healthcare professionals. Anchored by its culture of innovation and creativity, its 2,000+ experts enable modern medicines and scientific advances to meet and exceed their potential. Learn more at www.realchemistry.com. About Spring & Bond Spring & Bond is a digital media agency and consultancy specializing in helping pharmaceutical and medical device manufacturers create robust, omnichannel media strategies for both healthcare professionals (HCPs) and consumer audiences. Herbert Group emphasize transparency and client empowerment through comprehensive services, including customer journey planning, media strategy and activation, technology evaluation, in-house capability development, and training. Media: Please email its team at [email protected]. More News From Real Chemistry NEW YORK-( BUSINESS WIRE )-Real Chemistry announces Meenakshi Yadav as Chief AI Products and Solutions Officer, marking a strategic leap in its AI journey... NEW YORK-( BUSINESS WIRE )-Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare sector, today announced the launch of HealthGEO... NEW YORK-( BUSINESS WIRE )-REAL CHEMISTRY DEEPENS MEDIA AND TECHNOLOGY EDGE WITH ACQUISITION OF GREATER THAN ONE...
Real Chemistry strengthens media and omnichannel leadership with acquisition of Spring & Bond. Second Acquisition in Three Months Builds Momentum NEW YORK - Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare industry, continues to strengthen its media capabilities by acquiring Spring & Bond. A digital media agency known for its omnichannel-first approach and data-driven solutions, Spring & Bond is focused exclusively on healthcare, working with leading healthcare clients. This advertisement has not loaded yet, but your article continues below. "Real Chemistry is redefining the future of media with a focus on precision over scale. Our expanded media group offers omni-first precision marketing, which is essential for healthcare marketers aiming for personalized audience messaging," said Kevin Johnson, Group President and Managing Partner of Real Chemistry. "Spring & Bond brings a deep knowledge of the healthcare ecosystem, and advanced data and technology capabilities, enabling our clients to connect more meaningfully and effectively with their target audiences." This acquisition follows Real Chemistry's July acquisition of Greater Than One. Together, Real Chemistry's media group now provides end-to-end media activation solutions with over 250 dedicated experts. This includes: * Starting with the right data and healthcare expertise to understand audiences and inform content strategies * Proprietary planning tools that can drive channel strategy and predict future impact * Connecting first-party data across channels to reach precise audiences * True end to end omnichannel strategy, orchestration and execution * Agile, automated measurement, reporting, and optimization Elizabeth Beringer, President and Founder of Spring & Bond, will continue to lead the team, reporting to Johnson. "Joining Real Chemistry enables us to bring even more tools, insights and expertise to our clients," said Elizabeth Beringer. "Finding a partner like Real Chemistry where the focus on clients, innovation and people match ours is the perfect combination." About Real Chemistry Real Chemistry is a commercialization partner to the world's most successful life sciences and healthcare companies. As a leading provider of AI-powered marketing, communications, medical communications and precision media, Herbert Group help the healthcare industry better understand, reach, and engage communities, patients and healthcare professionals. Anchored by its culture of innovation and creativity, its 2,000+ experts enable modern medicines and scientific advances to meet and exceed their potential. Learn more at www.realchemistry.com. About Spring & Bond Spring & Bond is a digital media agency and consultancy specializing in helping pharmaceutical and medical device manufacturers create robust, omnichannel media strategies for both healthcare professionals (HCPs) and consumer audiences. Herbert Group emphasize transparency and client empowerment through comprehensive services, including customer journey planning, media strategy and activation, technology evaluation, in-house capability development, and training.